Genomic Valley Biotech Limited

Equities

GVBL6

INE574D01010

Market Closed - Bombay S.E. 03:30:56 03/07/2024 pm IST 5-day change 1st Jan Change
52.7 INR -4.68% Intraday chart for Genomic Valley Biotech Limited -7.77% +40.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024 CI
Genomic Valley Biotech Limited Announces Change in Corporate Office Address CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Genomic Valley Biotech Limited Announces Resignation of Mrs. Jyoti Bansal as Non-Executive (Independent) Director of the Company Effective December 14, 2023 CI
Genomic Valley Biotech Limited Announces Resignation of Parul Agrawal as Non-Executive (Non-Independent) Director and Reconstitution of Committees CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Genomic Valley Biotech Limited Announces Executive Changes CI
Genomic Valley Biotech Limited Approves Shifting of Registered Office CI
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer CI
Genomic Valley Biotech Limited Announces Executive Changes CI
Genomic Valley Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Genomic Valley Biotech CFO Steps Down MT
Genomic Valley Biotech Limited Announces CFO Changes CI
Genomic Valley Biotech Limited Announces Change in Directorate CI
Genomic Valley Biotech Limited Announces Resignation of Mr. Pritam as Company Secretary / Compliance Officer CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Genomic Valley Biotech Limited Announces Appointment of Mr. Pritam as Company Secretary and Compliance Officer CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Genomic Valley Biotech Turns to Net Profit in Fiscal Q1 MT
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Genomic Valley Biotech Limited Announces Resignation of Hanurnan Prasad as Company Secretary and Compliance Officer CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI